These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25656082)

  • 41. CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003.
    Stöhr W; Dunn D; Porter K; Hill T; Gazzard B; Walsh J; Gilson R; Easterbrook P; Fisher M; Johnson M; Delpech V; Phillips A; Sabin C;
    HIV Med; 2007 Apr; 8(3):135-41. PubMed ID: 17461856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunovirological discordance among female sex workers who start antiretroviral therapy in Burkina Faso.
    Bazié WW; Somé DY; Traoré IT; Sanon A; Konaté I; Tassembedo S; Taofiki AO; Kania D; Ouédraogo A; Vuylsteke B; Gilbert C; Meda N; Ouédraogo AS; Nagot N
    BMC Infect Dis; 2022 Feb; 22(1):117. PubMed ID: 35114959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations.
    Cunningham WE; Nance RM; Golin CE; Flynn P; Knight K; Beckwith CG; Kuo I; Spaulding A; Taxman FS; Altice F; Delaney JA; Crane HM; Springer SA
    BMC Infect Dis; 2019 Oct; 19(1):913. PubMed ID: 31664910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
    Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.
    Gare J; Kelly-Hanku A; Ryan CE; David M; Kaima P; Imara U; Lote N; Crowe SM; Hearps AC
    PLoS One; 2015; 10(8):e0134918. PubMed ID: 26244516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.
    Duarte HA; Harris DR; Tassiopoulos K; Leister E; Negrini SF; Ferreira FF; Cruz ML; Pinto J; Allison S; Hazra R;
    Braz J Infect Dis; 2015; 19(3):263-71. PubMed ID: 25743569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study.
    Farmer A; Wang X; Ganesan A; Deiss RG; Agan BK; O'Bryan TA; Akers K; Okulicz JF
    AIDS Res Ther; 2016; 13():16. PubMed ID: 27006682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy.
    Benning L; Mantsios A; Kerrigan D; Coleman JS; Golub E; Blackstock O; Konkle-Parker D; Philbin M; Sheth A; Adimora AA; Cohen MH; Seidman D; Milam J; Kassaye SG; Taylor T; Murray M
    BMC Womens Health; 2020 Jul; 20(1):152. PubMed ID: 32711509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.
    Barlow-Mosha LN; Bagenda DS; Mudiope PK; Mubiru MC; Butler LM; Fowler MG; Musoke PM
    Afr Health Sci; 2012 Sep; 12(3):249-58. PubMed ID: 23382737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia.
    Bartlett AW; Lumbiganon P; Kurniati N; Sudjaritruk T; Mohamed TJ; Hansudewechakul R; Ly PS; Truong KH; Puthanakit T; Nguyen LV; Chokephaibulkit K; Do VC; Kumarasamy N; Nik Yusoff NK; Fong MS; Watu DK; Nallusamy R; Sohn AH; Law MG;
    J Adolesc Health; 2019 Nov; 65(5):651-659. PubMed ID: 31395514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.